Vitamins and Lenvatinib drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vitamins (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e) and Lenvatinib (lenvatinib). Common drug interactions include hypertension among females and hyponatraemia among males.

The phase IV clinical study analyzes what interactions people have when they take Vitamins and Lenvatinib. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.

What is Vitamins?

Vitamins has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 122,456 Vitamins users. Check the latest studies of Vitamins.

What is Lenvatinib?

Lenvatinib has active ingredients of lenvatinib. eHealthMe is studying from 3,587 Lenvatinib users. Check the latest studies of Lenvatinib.



On Jul, 13, 2026

52 people who take Vitamins and Lenvatinib together, and have interactions are studied.

Vitamins and Lenvatinib drug interactions.

What are the common drug interactions of Vitamins and Lenvatinib, by gender? *:

female:

  1. Hypertension (high blood pressure)
  2. Malignant neoplasm progression (cancer tumour came back)
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Dyspnoea (difficult or laboured respiration)
  5. Infusion related reaction
  6. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  7. Epistaxis (bleed from the nose)
  8. Syncope (loss of consciousness with an inability to maintain postural tone)
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  10. Lymphoedema (localized fluid retention and tissue swelling)

male:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Hepatitis (inflammation of the liver)
  3. Gastroenteritis (inflammation of stomach and intestine)
  4. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  5. Platelet count decreased
  6. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  7. Small intestinal obstruction (blockage in small intestine)
  8. White blood cell count decreased
  9. Abdominal pain
  10. Aneurysm ruptured (expansion of the aneurysm reaches a point where the wall becomes too thin, the aneurysm will rupture)

What are the common drug interactions of Vitamins and Lenvatinib, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abdominal pain

20-29:

n/a

30-39:

  1. Hypertension (high blood pressure)
  2. Malignant neoplasm progression (cancer tumour came back)

40-49:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Diarrhoea infectious (bacteria, viruses, and other germs can cause diarrhoea)

50-59:

  1. Hepatitis (inflammation of the liver)
  2. Dyspnoea (difficult or laboured respiration)
  3. Hypertension (high blood pressure)
  4. Infusion related reaction
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  7. Electrolyte imbalance
  8. Hyperglycaemia (high blood sugar)
  9. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  10. Neutropenia (an abnormally low number of neutrophils)

60+:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Rectal haemorrhage (bleeding from anus)
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Biliary obstruction
  5. Cardiac arrest
  6. Gastroenteritis (inflammation of stomach and intestine)
  7. Headache (pain in head)
  8. Hypovolaemic shock (shock caused by severe blood or fluid loss)
  9. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  10. Platelet count decreased

What are the existing conditions these people have? *

  1. Oesophageal Adenocarcinoma (a cancer tumour of an epithelium in oesophagus): 8 people, 15.38%
  2. Renal Cell Carcinoma (a kidney cancer): 5 people, 9.62%
  3. Hepatocellular Carcinoma (liver cancer): 4 people, 7.69%
  4. Endometrial Cancer: 3 people, 5.77%

* Approximation only. Some reports may have incomplete information.

Do you take Vitamins and Lenvatinib?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vitamins and Lenvatinib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vitamins:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lenvatinib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vitamins and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lenvatinib and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e and lenvatinib (the active ingredients of Vitamins and Lenvatinib, respectively), and Vitamins and Lenvatinib (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: